Literature DB >> 15147308

Effects of hypocretin2-saporin and antidopamine-beta-hydroxylase-saporin neurotoxic lesions of the dorsolateral pons on sleep and muscle tone.

Carlos Blanco-Centurion1, Dmitry Gerashchenko, Rafael J Salin-Pascual, Priyattam J Shiromani.   

Abstract

The hypocretin neurons have been implicated in regulating sleep-wake states as they are lost in patients with the sleep disorder narcolepsy. Hypocretin (HCRT) neurons are located only in the perifornical region of the posterior hypothalamus and heavily innervate pontine brainstem neurons, such as the locus coeruleus (LC), which have traditionally been implicated in promoting arousal. It is not known how the hypocretin innervation of the pons regulates sleep-wake states as pontine lesions have never been shown to increase sleep. It is likely that in previous studies specific neurons were not lesioned. Therefore, in this study, we applied saporin-based neurotoxins to the dorsolateral pons and monitored sleep in rats. Anti-dopamine-beta-hydroxylase-saporin killed the LC neurons but sleep was affected only during a two hour light-dark transition period. Application of hypocretin2-saporin killed fewer LC neurons relative to other adjacent neurons. This occurred because the LC neurons possess the hypocretin receptor 1 but the ligand hypocretin 2 binds to this receptor with less affinity relative to the hypocretin receptor 2. The hypocretin2-saporin lesioned rats compared to controls had increased sleep during the dark period and displayed increased limb movements during REM sleep. None of the lesioned rats had sleep onset REM sleep periods or cataplexy. We conclude that the hypocretin innervation to the pons functions to awaken the animal when the lights turn off (via its innervation of the LC), sustains arousal and represses sleep during the rest of the night (via a wider innervation of other pontine neurons), and modulates muscle tone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147308      PMCID: PMC1201541          DOI: 10.1111/j.0953-816X.2004.03366.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  67 in total

1.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

2.  Long-term effects of decreased noradrenergic central nervous system innervation on pain behavior and opioid antinociception.

Authors:  Luc Jasmin; Abdennacer Boudah; Peter T Ohara
Journal:  J Comp Neurol       Date:  2003-05-19       Impact factor: 3.215

3.  Relation of pontine choline acetyltransferase immunoreactive neurons with cells which increase discharge during REM sleep.

Authors:  P J Shiromani; D M Armstrong; G Bruce; L B Hersh; P M Groves; J C Gillin
Journal:  Brain Res Bull       Date:  1987-03       Impact factor: 4.077

4.  Subcortical waking and sleep during lateral hypothalamic "somnolence" in rats.

Authors:  S Shoham; P Teitelbaum
Journal:  Physiol Behav       Date:  1982-02

5.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

6.  Effects of hypocretin-saporin injections into the medial septum on sleep and hippocampal theta.

Authors:  D Gerashchenko; R Salin-Pascual; P J Shiromani
Journal:  Brain Res       Date:  2001-09-14       Impact factor: 3.252

7.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat.

Authors:  J J Hagan; R A Leslie; S Patel; M L Evans; T A Wattam; S Holmes; C D Benham; S G Taylor; C Routledge; P Hemmati; R P Munton; T E Ashmeade; A S Shah; J P Hatcher; P D Hatcher; D N Jones; M I Smith; D C Piper; A J Hunter; R A Porter; N Upton
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-14       Impact factor: 11.205

8.  Symposium: Normal and abnormal REM sleep regulation: REM sleep behaviour disorder: an update on a series of 96 patients and a review of the world literature.

Authors: 
Journal:  J Sleep Res       Date:  1993-12       Impact factor: 3.981

9.  Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine.

Authors:  Melissa S Hunsley; Richard D Palmiter
Journal:  Sleep       Date:  2003-08-01       Impact factor: 5.849

10.  [Effects of lesions in the pontine tegmentum on the sleep stages in the rat].

Authors:  B Roussel; J F Pujol; M Jouvet
Journal:  Arch Ital Biol       Date:  1976-06       Impact factor: 1.000

View more
  18 in total

1.  Disinhibition of perifornical hypothalamic neurones activates noradrenergic neurones and blocks pontine carbachol-induced REM sleep-like episodes in rats.

Authors:  Jackie W Lu; Victor B Fenik; Jennifer L Branconi; Graziella L Mann; Irma Rukhadze; Leszek Kubin
Journal:  J Physiol       Date:  2007-05-10       Impact factor: 5.182

Review 2.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

Review 3.  Neurobiology of waking and sleeping.

Authors:  Barbara E Jones
Journal:  Handb Clin Neurol       Date:  2011

4.  Transplantation of hypocretin neurons into the pontine reticular formation: preliminary results.

Authors:  Oscar Arias-Carrión; Eric Murillo-Rodriguez; Man Xu; Carlos Blanco-Centurion; Rene Drucker-Colín; Priyattam J Shiromani
Journal:  Sleep       Date:  2004-12-15       Impact factor: 5.849

5.  Knockdown of orexin type 1 receptor in rat locus coeruleus increases REM sleep during the dark period.

Authors:  Lichao Chen; James T McKenna; Yunren Bolortuya; Stuart Winston; Mahesh M Thakkar; Radhika Basheer; Ritchie E Brown; Robert W McCarley
Journal:  Eur J Neurosci       Date:  2010-11       Impact factor: 3.386

6.  Effects of saporin-induced lesions of three arousal populations on daily levels of sleep and wake.

Authors:  Carlos Blanco-Centurion; Dmitry Gerashchenko; Priyattam J Shiromani
Journal:  J Neurosci       Date:  2007-12-19       Impact factor: 6.167

7.  Sleep allostasis in chronic sleep restriction: the role of the norepinephrine system.

Authors:  Youngsoo Kim; Lichao Chen; Robert W McCarley; Robert E Strecker
Journal:  Brain Res       Date:  2013-08-02       Impact factor: 3.252

Review 8.  Perspectives on the rapid eye movement sleep switch in rapid eye movement sleep behavior disorder.

Authors:  Vetrivelan Ramaligam; Michael C Chen; Clifford B Saper; Jun Lu
Journal:  Sleep Med       Date:  2013-06-13       Impact factor: 3.492

9.  Hypocretin-2 saporin lesions of the ventrolateral periaquaductal gray (vlPAG) increase REM sleep in hypocretin knockout mice.

Authors:  Satvinder Kaur; Stephen Thankachan; Suraiya Begum; Meng Liu; Carlos Blanco-Centurion; Priyattam J Shiromani
Journal:  PLoS One       Date:  2009-07-22       Impact factor: 3.240

10.  Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis.

Authors:  A Nuñez; M L Rodrigo-Angulo; I De Andrés; M Garzón
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.